Semaglutide mimics the natural hormone GLP-1, which is produced in the gut and plays a key role in regulating appetite and food intake. By activating GLP-1 receptors in the brain, semaglutide helps reduce hunger, thereby reducing calorie intake.
Semaglutide slows the rate at which food leaves the stomach and enters the small intestine, a process known as delayed gastric emptying. This delayed gastric emptying leads to a prolonged feeling of fullness, which further reduces food intake.
Semaglutide has been shown to increase energy expenditure and promote fat burning, leading to weight loss and improved body composition. It may also have a positive effect on lipid metabolism, contributing to favorable changes in cholesterol and triglyceride levels.
The product maintains a high purity standard of over 99% (>99%).
It is supplied as a freeze-dried powder and administered via subcutaneous injection.
It comes in 10mg, 15mg, 20mg, and 30mg specifications. Strength options include 0.25 mg or 0.5 mg dose pens, 1 mg dose pens, and 2 mg dose pens.
Semaglutide mimics the GLP-1 hormone produced in the gut, activating GLP-1 receptors in the brain to decrease hunger and lower overall calorie intake.
Delayed gastric emptying slows down the process of food leaving the stomach into the small intestine, extending feelings of fullness and aiding weight loss.
It boosts energy expenditure, promotes fat burning, and supports healthy lipid metabolism by creating positive changes in cholesterol and triglyceride levels.